<?xml version="1.0" encoding="UTF-8"?>

<RegulatedAuthorization xmlns="http://hl7.org/fhir">
  <id value="cfsb2023900992766"/>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative</b></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource "cfsb2023900992766" </p></div><p><b>identifier</b>: id: EU/1/16/1157/003 (OFFICIAL)</p><p><b>subject</b>: <a href="MedicinalProductDefinition-cfsb7123030148537.html">MedicinalProductDefinition/cfsb7123030148537</a></p><p><b>type</b>: Marketing Authorisation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#/#100000072062)</span></p><p><b>description</b>: Suliqua 100 units/ml + 33 microgram/ml solution for injection in x3 pre-filled pens</p><p><b>region</b>: European Union <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (unknown#eu)</span></p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://build.fhir.org/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2017-01-11T13:28:17Z</p><p><b>validityPeriod</b>: 2017-01-11T13:28:17Z --&gt; (ongoing)</p><p><b>holder</b>: <a href="Organization-cfsb6005885654359.html">Organization/cfsb6005885654359</a> "Sanofi-Aventis Groupe"</p><p><b>regulator</b>: <a href="Organization-cfsb1639015880655.html">Organization/cfsb1639015880655</a> "European Medicines Agency"</p></div>
  </text>
  <identifier>
    <use value="official"/>
    <system value="https://spor.ema.europa.eu/rmswi/#/"/>
    <value value="EU/1/16/1157/003"/>
  </identifier>
  <subject>
    <reference value="MedicinalProductDefinition/cfsb7123030148537"/>
  </subject>
  <type>
    <coding>
      <system value="https://spor.ema.europa.eu/rmswi/"/>
      <code value="/#100000072062"/>
    </coding>
    <text value="Marketing Authorisation"/>
  </type>
  <description value="Suliqua 100 units/ml + 33 microgram/ml solution for injection in x3 pre-filled pens"/>
  <region>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="eu"/>
    </coding>
    <text value="European Union"/>
  </region>
  <status>
    <coding>
      <system value="http://hl7.org/fhir/publication-status"/>
      <code value="active"/>
    </coding>
    <text value="Active"/>
  </status>
  <statusDate value="2017-01-11T13:28:17Z"/>
  <validityPeriod>
    <start value="2017-01-11T13:28:17Z"/>
  </validityPeriod>
  <holder>
    <reference value="Organization/cfsb6005885654359"/>
  </holder>
  <regulator>
    <reference value="Organization/cfsb1639015880655"/>
  </regulator>
</RegulatedAuthorization>